EGFR/c-Met and mTOR signaling are predictors of survival in non-small cell lung cancer

BACKGROUND: EGFR/c-Met activation/amplification and co-expression, mTOR upregulation/activation, and Akt/Wnt signaling upregulation have been individually associated with more aggressive disease and characterized as potential prognostic markers for lung cancer patients. METHODS: Tumors obtained from...

Descripción completa

Detalles Bibliográficos
Autores principales: Crees, Zachary D, Shearrow, Caleb, Lin, Leo, Girard, Jennifer, Arasi, Kavin, Bhoraskar, Aayush, Berei, Joseph, Eckburg, Adam, Anderson, Austin D., Garcia, Christian, Munger, Ariana, Palani, Sunil, Smith, Thomas J, Sreenivassappa, Shylendra B, Vitali, Connie, David, Odile, Puri, Neelu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Advances in Treatment of Lung Cancer Patients with Targetable Mutations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493230/
https://www.ncbi.nlm.nih.gov/pubmed/32973931
http://dx.doi.org/10.1177/1758835920953731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493230/
https://www.ncbi.nlm.nih.gov/pubmed/32973931
http://dx.doi.org/10.1177/1758835920953731

Ejemplares similares